We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
WST

Price
271.07
Stock movement up
+13.30 (5.16%)
Company name
West Pharmaceutical Services Inc
Exchange
(NYSE
,
Currency
USD
)
Sector
Healthcare >
Medical Instruments & Supplies
Market cap
19.50B
Ent value
19.93B
Price/Sales
6.46
Price/Book
6.39
Div yield
0.32%
Div growth
5.51%
Growth years
28
FCF payout
-
Trailing P/E
39.66
Forward P/E
34.85
PEG
4.13
EPS growth
15.84%
1 year return
-10.86%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-11-21

DIVIDENDS

Dividend yield - 5y

Loading...
Dividend yield data
Dividend per share0.88
Dividend yield0.32%
Payout frequencyQuarterly
Maximum yield0.44%
Average yield0.33%
Minimum yield0.24%
Discount to avg yield-2.74%
Upside potential-2.67%
Yield as % of max yield73.57%

Yield distribution (inverse percentile) - 5y

Loading...
Yield distribution data
Dividend yield0.32%
Current yield distribution61.35%
Yield at 100% (Min)0.24%
Yield at 90%0.25%
Yield at 80%0.26%
Yield at 50% (Median)0.35%
Yield at 20%0.38%
Yield at 10%0.40%
Yield at 0% (Max)0.44%

Dividend per share

Loading...
Dividend per share data
Years of growth28 years
CCC statusDividend Champion
Dividend per share0.88
Payout frequencyQuarterly
Ex-div date12 Nov 2025
EPS (TTM)-
EPS (1y forward)7.78
EPS growth (5y)15.84%
EPS growth (5y forward)9.60%

Dividend growth

Loading...
Please create a free account or log in to access this chart
Dividend growth data
WSTS&P500
DGR MR4.76%-13.74%
DGR TTM4.94%6.60%
DGR 3 years5.20%7.31%
DGR 5 years5.51%4.69%
DGR 10 years6.57%6.30%
DGR 15 years6.62%8.16%
Time since last change announced125 days
EPS growth (5y)15.84%
EPS growth (5y forward)9.60%

Payout ratio

Loading...
Please create a free account or log in to access this chart
Payout ratio data
EPS coverageFCF coverage
TTM--
Average--
Forward11.31%-

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E39.66
Price to OCF28.11
Price to FCF51.44
Price to EBITDA25.38
EV to EBITDA25.93

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales6.46
Price to Book6.39
EV to Sales6.60

FINANCIALS

Per share

Loading...
Per share data
Current share count71.94M
EPS (TTM)-
FCF per share (TTM)-

Income statement

Loading...
Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)7.78

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash628.50M
Net receivables652.50M
Total current assets1.82B
Goodwill110.60M
Intangible assets8.90M
Property, plant and equipment0.00
Total assets4.11B
Accounts payable255.80M
Short/Current long term debt303.00M
Total current liabilities635.40M
Total liabilities1.05B
Shareholder's equity3.05B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open259.80
Daily high272.06
Daily low258.85
Daily Volume650K
All-time high471.34
1y analyst estimate350.77
Beta1.17
EPS (TTM)-
Dividend per share0.88
Ex-div date12 Nov 2025
Next earnings date-

Downside potential

Loading...
Downside potential data
WSTS&P500
Current price drop from All-time high-42.49%-4.13%
Highest price drop-59.61%-19.00%
Date of highest drop8 Apr 20258 Apr 2025
Avg drop from high-44.25%-2.73%
Avg time to new high-6 days
Max time to new high282 days89 days
COMPANY DETAILS
WST (West Pharmaceutical Services Inc) company logo
Marketcap
19.50B
Marketcap category
Large-cap
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
Employees
10600
SEC filings
CEO
Eric Green
Country
USA
City
Exton
Stock type
Common stock
CCC status
Dividend Champion
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...